HebeCell
Business Services · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
21 Strathmore Rd, Natick, Massachusetts,...Phone Number
(508) 545-2190Website
www.hebecellcorp.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About HebeCell
HebeCell is a biotechnology company developing NK cell therapeutics based on its proprietary 3D-pluripotent stem cell (PSC) platform for the treatment of cancer, viral infection, and autoimmune diseases. The company is based in Natick, Massachusetts.Explore more
HebeCell Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is HebeCell your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on HebeCell recently announced quarterly report
Click to see if HebeCell had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at HebeCell
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if HebeCell is spiking on competitors!
HebeCell, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once HebeCell has new funding data
Product Launch: Get notified when HebeCell launches new products
Check if HebeCell has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to HebeCell
Compare insights from companies similar to HebeCell, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
HebeCell is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
HebeCell is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about HebeCell.
HebeCell financials insights
Gather financial insights about HebeCell, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Other Financing Round
$10M
HebeCell Tech Stack
A closer look at the technologies used by HebeCell
See more technologies
Most Recent Scoops
Event
Product Marketing, Events, Business Intelligence, Engineering, Analytics & Insights, Research & Development, Sales, Search, Software, Bioengineering, Laboratory Operations, Clinical Operations, Field Marketing, Operations
Open Position
Partnership
Partnership, Engineering, Research & Development
Funding
HebeCell News & Media
HebeCell and Vuja De Sciences Announce Strategic Collaboration
Signed R&D collaboration agreement and a memorandum of understanding to develop and commercialize game-changing cancer therapies based on iPSC-derived NK cells in combination with small molecule drugs for preventing and treating metastatic cancer, the cause of 90% of cancer deaths (PRWeb April 06, 2022) Read the full story at https://www.prweb.com/releases/2022/4/prweb18598127.htmJacobio Announces Strategic Investment in Hebecell to Further Develop iPSC-NK Cell Therapy
BEIJING and SHANGHAI and BOSTON, Aug. 31, 2021 /PRNewswire/ -- Jacobio Pharmaceuticals ("Jacobio", 1167.HK) announced a strategic investment in the US-based biotech company Hebecell on August 31. Jacobio will collaborate with Hebecell to develop the next-generation natural killer cell therapy based on induced pluripotent stem cells (iPSC-NK). Once the deal is completed, Jacobio chairman and CEO Dr. Yinxiang Wang will be appointed as Chairman of Hebecell. "Cell therapy is at the forefront of cancProteintech en HebeCell kondigen samenwerking aan voor van nanobody iPSC afgeleide naturalkillercellen
CHICAGO en NATICK, Massachusetts--(BUSINESS WIRE)--Proteintech en HebeCell kondigen hun samenwerkingsverband aan om gepatenteerde op nanobody gebaseerde chimeric antigen receptor (nCAR)-technologie te ontwikkelen voor de ontwikkeling en commercialisering van iPSC afgeleide naturalkillercellen (iPSC-nCAR-NK), een veelbelovende cellulaire immunotherapiebehandeling voor kanker en andere ziekten. De recente overname van nanobody-fabrikant, ChromoTek, door Proteintech heeft hen tot een toonaangevendProteintech and HebeCell Announce Collaboration on Nanobody iPSC-derived Natural Killer Cells
CHICAGO & NATICK, Massachusetts--(BUSINESS WIRE)-- #HebeCell--Proteintech and HebeCell announce their collaborative partnership to develop proprietary nanobody based chimeric antigen receptor (nCAR) technology for the development and commercialization of iPSC-derived natural killer (iPSC-nCAR-NK) cells, a promising cellular immunotherapy treatment for cancer and other diseases. Proteintech’s recent acquisition of nanobody manufacturer, ChromoTek, has made them a leading player in the nanobody sp
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding HebeCell
Sign Up For FreeTo access detailed company insights
HebeCell is a biotechnology company developing NK cell therapeutics based on its proprietary 3D-pluripotent stem cell (PSC) platform for the treatment of cancer, viral infection, and autoimmune diseases. The company is based in Natick, Massachusetts.... Read More
